Price | Negotiable |
MOQ | 1000 |
Delivery Time | 7 Days |
Brand | WWHS |
Place of Origin | CN |
Certification | ISO 13485, CE |
Model Number | S100-β |
Packaging Details | Colorful Paper Box |
Payment Terms | L/C, T/T |
Supply Ability | 10000 Kits per Week |
Place of Origin | CN | Warranty | 12 Months |
Packaging Details | Colorful Paper Box | Product Name | S100-β Rapid Quantitative Test Kit |
Model Number | S100-β | Supply Ability | 10000 Kits per Week |
Feature | High Sensitivity, High Accuracy | Certification | ISO 13485, CE |
Brand Name | WWHS | Payment Terms | L/C, T/T |
Applicable Instruments | NIR-1000 Dry Fluorescent Immunoassay Analyzer | Package Specification | 25 Tests |
Price | Negotiable | Delivery Time | 7 Days |
Minimum Order Quantity | 1000 | Sample Buffer | 25 Vials |
【Product Name】
Diagnostic Kit for S100β protein(Immunochromatographic assay)
【Packing Specification】
25 Tests/kit
【Intended Use】
The kit is used for quantitative determination of S100β in human whole blood, serum or plasma. Clinically, by detecting the expression of S100β protein, we can judge the degree of brain injury and evaluate the prognosis of patients.
【Test principle】
The Diagnostic Kit for S100β is a one-step chromatographic sandwich immunoassay designed for the quantitative measurement of S100β. The S100β antigen in the sample was first bound with the conjugated compound of fluorescent labeled S100β monoclonal antibody, then moved and combined with another S100β monoclonal antibody fixed on the nitrocellulose membrane, and the double antibody sandwich complex was formed at the detection line of the cellulose nitrate membrane. The quantitative detection results were obtained by NIR-1000 dry fluoroimmunoassay analyser.
【Components】
Name | Quantity | Component |
Test cards | 25 | The product consists of fluorescent pat (coated with fluorescently-labeled S100β monoclonal antibody), nitrocellulose membrane (coated with S100β monoclonal antibody ), absorbent paper and PVC soleplate. |
Sample diluent | 25 (200µL/ tube) | Tris-HCl buffer |
ID card | 1 | With specific stand curve file |
The components in different batches of kits cannot be used interchangeably.
【Storage Conditions and Validity】
The kit should be stored at 4℃~30℃, out of direct sunlight. It is valid for 18 months. The test card should be used within 15 minutes after unsealing under the environment of 15℃~30℃ and 20% ~ 90% relative humidity. The sample buffer is disposable and used immediately after opening the cap.
The production date, batch number and expiration date are shown in the outer package of the product.
【Applicable Instrument】
NIR-1000 dry fluoroimmunoassay analyser produced by WWHS Biotech. Inc.
【Sample Requirements】
【Test procedure】
【Reference interval】
S100β normal reference value is less than 0.20ng/mL. It is strongly recommended that each laboratory should determine its own normal and abnormal values.
【Interpretation of test results】
【Limitation of test method】
3. The triglyceride content in the sample does not exceed 15mg/mL, the hemoglobin content does not exceed 5mg/mL, the bilirubin content does not exceed 0.5mg/mL, the content of neuron-specific enolase does not exceed 200ng/mL, the content of glial fibrillary acidic protein does not exceed 5ng/mL, the content of IL-6 does not exceed 200pg/mL, the content of tumor necrosis factor does not exceed 200pg/mL, the content of albumin does not exceed 60mg/mL, the content of fibroblast growth factor does not exceed 20ng/mL, the cholesterol does not exceed 10mg/mL, the content of total protein does not exceed 120mg/mL, and the relative deviation of the measurement results does not exceed ±15.0%.
4. When S100β concentration of samples reaches 40.00ng/mL, there is no hook effect.
6. When RF concentration of samples is less than 2000IU/mL, relative deviation of test result is limited to ±15.0%.
7. For samples exceeding the linearity range, test cannot be conducted after dilution.
【Performance】
1. Limits of detection
No higher than 0.05ng/mL
2. Accuracy
The relative deviation to the target value is limited to ±15.0%.
The within and between assay coefficient of variations are within 15%.
Within the linear range [0.05,10.00]ng/mL, the linear correlation coefficient R≥0.990.
【Note】
1. The kit can be used for in vitro diagnosis only.
2. Test card and buffer solution are single-use and they cannot be reused.
3. Please check the integrity and validity of the kit package before use, and then open the package. When it is stored at low temperature, it should be restored to room temperature (15℃ ~ 30℃) before opening the package for use. The reagents with damaged inner package and beyond the validity period cannot be used.
4. Take the test card out of the aluminum foil bag and carry out experiment in 15min. Do not place it in the air for a long time to avoid dampness.
5. It is required to strictly comply with the requirements for sample collection and storage. If the sample is turbid, please centrifuge and precipitate it before use.
6. The kit used should be disposed of as latent infective material, and all samples, reagents and latent contaminants should be disinfected and disposed of according to relevant local regulations.
WWHS POCT Assay List
Cardiac | ||||||
cat#. | Product item | Specimen | Reaction Time | Measure Range | Clinical Range | Itended Use |
1 | cTnI | WB/Serum/Plasma | 12min. | 0.1-40ng/ml | <0.3ng/ml | several heart diseases including myocardial infarction and heart failure. |
2 | Myo | WB/Serum/Plasma | 12min. | 5-400ng/ml | <58ng/ml | acute myocardial infarction (AMI) in early stage. |
3 | CK-MB | WB/Serum/Plasma | 12min. | 1-200ng/ml | <5ng/ml | acute myocardial infarction (AMI) in early stage. |
4 | NT-proBNP | WB/Serum/Plasma | 10min. | 20-35000pg/ml |
Under
75:0~347pg/mL, Over 75:0~449pg/mL |
heart failure . |
5 | D-Dimer | WB/Plasma | 10min. | 40-10000ng/ml | <500ng/ml | disseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc. |
6 | cTnI+Myo+CKMB | WB/Serum/Plasma | 12min. | same with single item | same with single item | Triple marker of myocardial infarction. |
7 | ST2 | WB/Serum/Plasma | 10min. | 10-400ng/ml | <35ng/ml | heart failure . |
8 | Lp-PLA2 | WB/Serum/Plasma | 10min. | 10-900ng/ml | <175ng/ml | Risk evaluation of ACS and atherosclerotic ischemic stroke patients. |
9 | S100-β | WB/Serum/Plasma | 10min. | 0.05-10ng/ml | <0.2ng/ml | Cerebral infarction, cerebral injury. |
Inflammation | ||||||
10 | CRP / hs-CRP | WB/Serum/Plasma | 3min. | 0.5-200mg/L | CRP<10mg/L,hs-CRP<1mg/L | nonspecficity inflammatory marker. |
11 | SAA | Serum | 5min. | 1-200mg/L | <10mg/L | inflammation&infection. |
12 | PCT | WB/Serum/Plasma | 10min. | 0.2-100ng/ml | <0.5ng/ml | Sepsis |
13 | CRP+SAA | WB/Serum/Plasma | 5min. | same with single item | same with single item | inflammation&infection. |
14 | IL-6 | WB/Serum/Plasma | 10min. | 5-4000pg/ml | 10pg/ml | diabetes,rheumatoid arthritis,etc |
Thyroid Hormone | ||||||
15 | TSH | Serum/Plasma | 15min. | 0.3-100mU/L | 0.35-5mU/L | hyperthyroidism and hypothyroidism |
16 | T3 | Serum/Plasma | 15min. | 0.5-10nmol/L | 1.3-3.1nmol/L | thyroid dysfunction |
17 | T4 | Serum/Plasma | 15min. | 5-300nmol/L | 66-181nmol/L | thyroid dysfunction |
Tumor Marker | ||||||
18 | AFP | Serum/Plasma | 15min. | 2.5-200ng/ml | <20ng/ml | pregnancy cancer |
19 | CEA | Serum/Plasma | 15min. | 1-200ng/ml | <5ng/ml | colon cancer, colorectal cancer,etc. |
20 | NSE | Serum/Plasma | 15min. | 1-400ng/ml | <16ng/ml | non-small cell lung cancer |
21 | FOB | fecal specimens | 10min. | 50-1000ng/ml | <100ng/ml | Abnormal recessive gastrointestinal bleeding |
22 | PG II | Serum/Plasma | 15min. | 1-100ug/L | PGI/PGII>3.0 | gastric abnormalities |
23 | PG I | Serum/Plasma | 15min. | 2.5-200ug/L | >70ng/ml | gastric abnormalities |
24 | PSA | Serum/Plasma | 15min. | 0.5-40ng/ml | <4ng/ml | prostate cancer |
25 | FPSA | Serum/Plasma | 15min. | 0.1-10ng/ml | <1ng/ml | prostate cancer |
26 | CA12-5 | Serum/Plasma | 15min. | 20-500U/ml | <35U/ml | ovarian cancer |
27 | CA15-3 | Serum/Plasma | 15min. | 10-400U/ml | < 25 U/mL | breast cancer |
28 | HE4 | Serum/Plasma | 15min. | 50-2000pmol/L | <140 pmol/L | ovarian cancer |
29 | CA19-9 | Serum/Plasma | 15min. | 10-400U/ml | < 27 U/mL | pancreatic cancer |
30 | β-HCG | Serum/Plasma | 15min. | 5-400mIU/ml | <10 mIU/mL | Early pregrancy, ectopic HCG cancer,incomplete abortion |
31 | CK19(Cyfra21-1) | Serum/Plasma | 15min. | 0.5-50ng/ml | <2.5ng/ml | non-small cell lung cancer |
Interpretation of results
1.
This
reagent
is
only
used
for
auxiliary
detection.
If
the
test
results
are
abnormal,
it
should
be
reviewed
in
time
and
judged
in
combination
with
clinical
symptoms.
2.
For
samples
with
AFP
concentration
lower
than
2.5ng/ml
and
higher
than
200ng/ml,
the
detection
results
are
reported
as
"<
2.5ng/ml"
and
">
200ng
/ml",
respectively.
Limitations
of
methods
1.
This
kit
is
only
used
to
detect
human
plasma/whole
blood
samples
2.
Due
to
the
limitations
of
immunoassay
methods
of
antigen
and
antibody
reaction,
the
results
cannot
be
used
as
the
only
basis
for
clinical
diagnosis,
but
should
be
evaluated
with
all
the
existing
clinical
and
experimental
data.
3.
The
content
of
triglyceride
in
the
sample
shall
not
exceed
15mg/ml,
the
content
of
hemoglobin
shall
not
exceed
5mg/ml,
and
the
content
of
bilirubin
shall
not
exceed
0.5mg/ml,
and
the
relative
deviation
of
the
test
results
shall
not
exceed
±15%.
4.
When
the
concentration
of
AFP
in
the
sample
is
less
than
20000ng/ml,
there
is
no
hook
effect.
5.
HAMA
effect
was
not
produced
when
the
concentration
of
human
anti
rat
in
the
sample
was
less
than
50ng/ml.
6.
When
RF
concentration
in
the
sample
is
less
than
2000IU/ml,
the
relative
deviation
of
the
test
results
is
within
±15%.
Applicable
Instrument
WWHS NIR-1000 dry fluoroimmunoassay analyser
Packing and Delivery
Packing:
Standard
packing,
neutral
packing,
OEM
packaging
are
welcome;
Delivery:
According
to
the
specific
quantity
of
the
product;
Payment:
Credit
Card,
Paypal,
Local
Bank,
Western
Union,
T/T,
etc.
Shipping:
International
Express,
by
Air,
by
Sea,
etc;